It’s the first study to show a PCSK9 inhibitor can reduce major events in high-risk patients who haven’t yet had one.

An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...

Researchers report early but encouraging results on an experimental gene-editing treatment for high cholesterol.

The approach is “very exciting,” but one expert says a lot more research is needed, especially around safety, before clinical ...

Doctor after doctor misdiagnosed or shrugged off Ruth Wilson's rashes, swelling, fevers, and severe pain for 6 years. She ...

One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is ...

Dangerously high levels of “bad” cholesterol and triglycerides may be reduced by gene editing, in what study researchers hope will be a “one and done” treatment.

A cutting-edge medical experiment in a small trial has demonstrated the effectiveness of a one-time CRISPR gene editing treatment in lowering cholesterol levels ...

In a small, short-term, Phase 2 clinical trial in adults, a first-of-its-kind medication reduced triglyceride levels in most ...

Increased exposure to artificial light at night is linked to higher stress-related activity in the brain, more inflammation in the arteries, and an increased risk for heart disease.

A single infusion of CRISPR Therapeutics' experimental gene therapy was safe and reduced levels of harmful LDL cholesterol and triglycerides by half in four people taking the highest dose, raising ...